» Articles » PMID: 38776887

PROVIT-CLOCK: A Potential Influence of Probiotics and Vitamin B7 Add-On Treatment and Metabolites on Clock Gene Expression in Major Depression

Abstract

Introduction: An increasing body of evidence suggests a strong relationship between gut health and mental state. Lately, a connection between butyrate-producing bacteria and sleep quality has been discussed. The PROVIT study, as a randomized, double-blind, 4-week, multispecies probiotic intervention study, aims at elucidating the potential interconnection between the gut's metabolome and the molecular clock in individuals with major depressive disorder (MDD).

Methods: The aim of the PROVIT-CLOCK study was to analyze changes in core clock gene expression during treatment with probiotic intervention versus placebo in fasting blood and the connection with the serum- and stool-metabolome in patients with MDD (n = 53). In addition to clinical assessments in the PROVIT study, metabolomics analyses with 1H nuclear magnetic resonance spectroscopy (stool and serum) and gene expression (RT-qPCR) analysis of the core clock genes ARNTL, PER3, CLOCK, TIMELESS, NR1D1 in peripheral blood mononuclear cells of fasting blood were performed.

Results: The gene expression levels of the clock gene CLOCK were significantly altered only in individuals receiving probiotic add-on treatment. TIMELESS and ARNTL gene expression changed significantly over the 4-week intervention period in both groups. Various positive and negative correlations between metabolites in serum/stool and core clock gene expression levels were observed.

Conclusion: Changing the gut microbiome by probiotic treatment potentially influences CLOCK gene expression. The preliminary results of the PROVIT-CLOCK study indicate a possible interconnection between the gut microbiome and circadian rhythm potentially orchestrated by metabolites.

References
1.
Kreuzer K, Reiter A, Birkl-Toglhofer A, Dalkner N, Morkl S, Mairinger M . The PROVIT Study-Effects of Multispecies Probiotic Add-on Treatment on Metabolomics in Major Depressive Disorder-A Randomized, Placebo-Controlled Trial. Metabolites. 2022; 12(8). PMC: 9414726. DOI: 10.3390/metabo12080770. View

2.
Hempel S, Newberry S, Ruelaz A, Wang Z, Miles J, Suttorp M . Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep). 2012; (200):1-645. PMC: 4780970. View

3.
Nikolova V, Smith M, Hall L, Cleare A, Stone J, Young A . Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis. JAMA Psychiatry. 2021; 78(12):1343-1354. PMC: 8444066. DOI: 10.1001/jamapsychiatry.2021.2573. View

4.
Monje F, Cicvaric A, Acevedo Aguilar J, Elbau I, Horvath O, Diao W . Disrupted Ultradian Activity Rhythms and Differential Expression of Several Clock Genes in Interleukin-6-Deficient Mice. Front Neurol. 2017; 8:99. PMC: 5360714. DOI: 10.3389/fneur.2017.00099. View

5.
Szentirmai E, Millican N, Massie A, Kapas L . Butyrate, a metabolite of intestinal bacteria, enhances sleep. Sci Rep. 2019; 9(1):7035. PMC: 6504874. DOI: 10.1038/s41598-019-43502-1. View